期刊文献+

骨癌痛大鼠鞘内注射U0126的抗痛觉过敏作用 被引量:3

The attenuate hyperalgesia effect of intrathecal U0126 in a rat model of bone cancer pain
下载PDF
导出
摘要 目的研究鞘内注射(it)U0126对骨癌痛大鼠机械痛敏的影响和对脊髓背角磷酸化cAMP反应元件结合蛋白(pCREB)表达的影响,探讨ERK-CREB信号转导通路在骨癌痛中的作用。方法①40只成年♀SD大鼠分为5组,假模型组Ⅰ和骨癌痛模型组Ⅱ、Ⅲ、Ⅳ、Ⅴ。建模后d 10每只大鼠分别it 10μg U0126、5%二甲亚砜10μl和U0126 0.1、1、10μg(U0126溶于10μl 5%二甲亚砜中),测机械性缩爪阈值(MWT)和双下肢负重差(WBD);②25只成年♀SD大鼠分为5组,T1、T2和T3组在制作骨癌痛模型后d 10,itU0126 10μg后1、6、24 h处死大鼠,M组为模型对照组,it5%二甲亚砜10μl后6 h处死大鼠,S组为空白对照组。免疫组化方法测定L4-6术侧脊髓背角pCREB免疫反应阳性神经元数量。结果鞘内注射U0126 1μg和10μg明显逆转了骨癌痛引起的机械痛敏;鞘内注射10μg U0126明显减少脊髓背角pCREB表达,且效果至少可持续6 h。结论 ERK-CREB通路可能参与骨癌痛。 Aim To investigate the effect of intrathecal (i. t. ) U0126 (MAPK kinase inhibitor)on the mechanical hyperalgesia and the expression of phosphoryl- ated cAMP response element binding protein(pCREB) in the dorsal horn of spinal cord following bone cancer pain in rats, trying to evaluate the role played by ERK-CREB signal transmission pathway in the mechanism of bone cancer pain. Methods ① 40 adult female SD rats were divided into five groups. Sham group I and bone cancer pain (BCP) group rats Ⅱ , Ⅲ, Ⅳ, Ⅴ received a bolus of 10 μg U0126, 5% DMSO 10 μl, U0126 0. 1, 1, 10 μg i. t. respectively on the 10th day after the model was made. Mechanical withdrawal threshold (MWT) and weight bearing difference (WBD) were measured;②25 adult female SD rats were divided into five groups. On the 10th day after the model was made, BCP rats of group T1 ,T2 and T3 were killed at 1, 6, 24 h after i. t. U0126 10 μg respectively. In group M, rats produced bone cancer pain only and were killed at 6h after i. t. 5% DMSO 10 μl; sham group S was as blank control; L4-6 segments of spinal cord were removed and the expression of pCREB was assessed by immunohistoehemieal analysis. Results Intrathecal U0126 1 μg and 10 μg signif-icantly reversed the mechanical hyperalgesia induced by bone cancer pain. Intrathecal U0126 10 μg significantly attenuated the activation of pCREB in the dorsal horn of spinal cord induced by BCP and the effects lasted for at least 6 h. Conclusion This study shows that ERK-CREB signal cascade is involved in the mechanism of bone cancer pain.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第7期948-951,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30872442 81000479) 江苏省卫生厅基金资助项目(NoH200855 H200917)
关键词 MAPK ERK 骨癌痛 cAMP反应性 脊髓 大鼠 鞘内注射 mitogen activated protein kinases ERK bone cancer pain cyclic AMP-responsive spinal cord rat intrathecal injection
  • 相关文献

参考文献8

  • 1Hoeger-Bement M K,Sluka K A.Phosphorylation of CREB and mechanical hyperalgesia is reversed by blockade of the cAMP pathway in a time-dependent manner after repeated intramuscular acid injections[J].Neurosci,2003,23:5437-45.
  • 2Lonze B E,Ginty D D.Function and regulation of CREB family transcription factors in thenervous system[J].Neuron,2002,35(4):605-23.
  • 3Ji R R,Woolf C J.Neuronal plasticity and signal transduction in nociceptive neurons:implications for the initiation and maintenance of pathological pain[J].Neurobio Dis,2001,8:1-10.
  • 4Miletic G,Pankratz M T,Miletic V.Increases in the phosphorylation of cyclic AMP response element binding[rotein (CREB) and decreases in the content of calcineyrin accompany thermal hyperalgesia following chronic constriction injury in rats[J].Pain,2002,99(3):493-500.
  • 5Ji R R,Befort K,Brenner G J,et al.ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity[J].Neurosci,2002,22(2):478-85.
  • 6姚明,杨建平,王丽娜,成浩,张艳兵,许期年,吴翼伟.腹水传代与体外培养Walker 256癌细胞系建立大鼠骨癌痛模型的可行性[J].中华医学杂志,2008,88(13):880-884. 被引量:61
  • 7唐元章,申文,刘苏,马正良,孙玉娥,张井浪,苏小虎,朱姗姗,宋学军.抑制小胶质细胞激活对骨癌痛小鼠疼痛维持的影响[J].中国药理学通报,2009,25(1):104-108. 被引量:9
  • 8杨建平,蒋豪.大鼠蛛网膜下腔埋管并长期留置操作的改进[J].中华麻醉学杂志,1993,13(2):110-112. 被引量:123

二级参考文献28

  • 1葛志军,戴体俊,曾因明,段世明.鞘内注射哌唑嗪对氯胺酮抗伤害作用的影响[J].中国药理学通报,2005,21(4):427-431. 被引量:5
  • 2成浩,杨建平,张艳兵,王丽娜,张慧娟.鞘内注射米诺环素减轻大鼠佐剂性关节炎性痛觉过敏[J].中国药理学通报,2007,23(5):658-661. 被引量:1
  • 3Rubens RD. Bone metastases-the clinical problem. Eur J Cancer, 1998, 34: 211-213.
  • 4Medhursta SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain, Pain, 2002, 96:129-140.
  • 5Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain, 2005, 118 : 125-136.
  • 6Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci ,1999, 19: 10886-10897.
  • 7Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res, 2005, 65 : 9426-9435.
  • 8Walker K. Fox AJ, Urban LA. Animal models for pain research. Mol Med Today, 1999, 5: 319-321.
  • 9Corbello Pereira SR, Darronqui E, Constantin J, et al. The urea cycle and related pathways in the liver of Walker-256 tumorbearing rats. Biochim Biophys Acta, 2004, 1688: 187-196.
  • 10Yao YM, Liu QG, Yang W, et al. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. Hepatobiliary Pancreat Dis Int, 2003, 2: 242-246.

共引文献170

同被引文献37

  • 1李印,周清华,孙芝琳,孙泽芳,王艳萍,覃扬,朱文,陈晓禾.靶向抑制ERK1/2信号传导通路对人高转移大细胞肺癌细胞株L9981恶性表型的影响[J].中国肺癌杂志,2005,8(6):504-509. 被引量:3
  • 2Roberts PJ, Der CJ. Targting the Raf-MEK-ERK mitogen-activated protein kinase for the treatment of cancer! J l. ()ncogene, 2007,26 (22) :3291 -3310.
  • 3Li Q, Wu J ,Zheng H ,et al. Discovery of 3-( 2-aminoethyl ) -5-( 3-phcn-yl-propylidene) -thiazolidine- 2,4-dione as a dual inhibitor of the Raf/ MEK/ERK and the PI3K/Akt signaling pathways[J]. Bioorganic & Medicinal Chemistry" Letters ,2010,20 ( 15 ) :4526 - 4530.
  • 4Olivier S,Robe P,Bours V. Can NF-kB be a target for novel and effi- cient anti-cancer agents ? [ J ]. Biochem Pharmacol, 2006,72 ( 9 ) : 1054 - 1068.
  • 5Mouawad R, Sebert M, Michels J, et al. Treatment for metastatic malig- nant melanoma:Old drugs and new strategies [ J ]. Critical Reviews in Oncology/Hematology,2010,74 ( 1 ) :27 - 39.
  • 6Ji Z, Flaherty KT, Tsao H, et al. Targeting the RAS pathway in melano- ma [ J ]. Trends in Molecular Medicine,2012,18 ( 1 ) :27 - 33.
  • 7Ji Z,Flaherty KT,Tsao H. Molecular therapeutic approaches to melano- ma [ J ]. Molecular Aspects of Medicine,2010,31 (2) : 194 - 204.
  • 8Fukazawa H, Noguchi K, Murakami Y, et al. Mitogen-activated protein/ extrace|lular signal- regulated kinase kinase (MEK) inhibitors restore anoikis sensilivity in human breast cancer cell lines with a constitutive- ly activated extracellular-regulated kinase (ERK) pathway [ J ]. Mol Cancer Ther,2002, l (5) : 303 - 309.
  • 9Lind CR, Gray CW, Person AG, et al. The mitogen-activated/extracel- lularsigrtal-regulated kinasse kinaset/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells [ J ]. Neuroscience ,2006,141 (4) : 1925 - 1933.
  • 10Tsubaki M, Satan T, hob T,et al. Reduction of metastasis, cell inva- sion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-in- duced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway [J]. Toxicol Appl Phamlacol,2012,259 (3) :402 -410.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部